“Not for human consumption” claims and UK law
Almost every research-peptide vial in the UK carries a “not for human consumption” or “research use only” label. This page explains what those labels actually do under UK medicines law — and what they cannot do.
The label has no special legal status
Nothing in the Human Medicines Regulations 2012 (HMR 2012) gives the phrase “not for human consumption” or “research use only” a defined legal meaning. The labels are marketing conventions, not exceptions carved into UK medicines law.
The relevant tests sit elsewhere in the same regulations:
- Regulation 2 (medicinal product definition). A product is a “medicinal product” if it is presented as having properties for treating or preventing disease in humans, or if it may be administered to humans with a view to restoring, correcting, or modifying a physiological function.
- Part 12 (advertising) and Part 14 (supply). If a product meets the medicinal-product definition, advertising and supply rules apply — and the absence of a UK marketing authorisation is a problem rather than a defence.
So the legal test is not what is printed on the vial. It is what the seller is doing with the product as a whole — the website copy, dosing tables, recommended schedules, accompanying syringes, influencer placements, testimonials, and target audience.
The “presentation” test in practice
A vial of an unlicensed peptide with these surrounding elements is presented as a medicine even if every page also says “research use only”:
- Dosing tables in mg, mcg, or units per kilogram body weight.
- Reconstitution guidance written in patient-friendly language with BAC water and insulin-syringe references.
- Suggested cycle lengths and on/off schedules.
- Before-and-after photos, athlete testimonials, weight-loss claims, or healing-time claims.
- Cross-sell with injection supplies (needles, alcohol swabs, sharps bins).
- Reviews, forum posts, or social-media content the seller links to or quotes back.
Any one of these on its own may not be decisive. The MHRA looks at the full picture. A “research only” label combined with consumer presentation is exactly the contradiction that brings the medicinal-product definition into play.
What the label DOES do
- Civil liability hedge. It is part of the seller’s case that they did not invite human use. It may shift some responsibility back to the buyer in a private dispute.
- Consumer-law signal. Against a misrepresentation claim it gives the seller a starting argument that they did not represent the product as fit for human use.
- Marketing hygiene. It satisfies a check on platforms (e.g. payment processors) that require some disclaimer language to be present.
What the label does NOT do
- It does not displace the MHRA’s analysis of whether the product is being presented as a medicine.
- It does not exempt the seller from advertising or supply offences under HMR 2012 Parts 12 and 14.
- It does not protect the consumer from the safety, quality, and sterility risks of an unlicensed compound. There is no Patient Information Leaflet, no licensed dosing, no batch testing regime, and no Yellow Card-equivalent recourse for a research chemical.
- It does not change the consumer’s legal exposure if they then on-supply to others (which can constitute a supply offence).
Consumer takeaway
Treating “not for human consumption” as a green light to self-administer is the opposite of what the label achieves. It signals that the product sits outside the licensed-medicine framework entirely. If a real adverse event occurs, there is no PIL to consult, no licensed prescriber accountable, no MHRA-overseen batch chain to interrogate, and no recall mechanism.
Red-flag claims
If you see wording like this on a seller, clinic, or social-media advert, treat it as a warning sign rather than a benefit.
“Research use only — but here's the full injection protocol”
The combination of the disclaimer and dosing instructions creates exactly the presentation contradiction MHRA looks at.
“Not for human consumption — see real customer results”
Customer-result imagery is presentation as a medicine, regardless of the disclaimer.
“Lab-grade only — bundle deal with insulin syringes”
Bundling with injection supplies is supply that anticipates human use.
“For research purposes — UK shipping, discreet packaging”
“Discreet packaging” is consumer-supply language, not research-supply language.
Sources & further reading
- Human Medicines Regulations 2012 — Regulation 2 (interpretation) — legislation.gov.uk
- Human Medicines Regulations 2012 (consolidated index) — legislation.gov.uk
- MHRA — gov.uk
- Report a problem with a medicine or medical device — gov.uk
Frequently asked questions
- Does “not for human consumption” make selling an unlicensed peptide legal?
- No. The MHRA's analysis turns on how a product is presented and the purpose for which it is supplied, not on a disclaimer printed on a label. A vial labelled “research only” but accompanied by dosing tables, reconstitution instructions, before-and-after photos, and an athlete testimonial is being presented as a medicine in everything but the label.
- Is there a UK statute that defines “not for human consumption”?
- No. The label has no special status in the Human Medicines Regulations 2012. The relevant tests are the medicinal-product definition in regulation 2 and the supply offences in Parts 12 and 14.
- Why do sellers use the label then?
- Largely as marketing hygiene and as an attempt to limit civil liability. It has limited regulatory effect against the MHRA, the ASA, or trading standards if the surrounding presentation contradicts it.
- What about “for laboratory use only” in scientific supply?
- Genuine research supply between accredited research institutions, with appropriate documentation, is a different category. The question is whether the supply chain looks like research supply or like consumer supply with a research label bolted on.
- Can I rely on the label as a consumer?
- No. Buying an unlicensed product on the strength of a “research only” disclaimer does not protect you from the safety risks. There is no licensed-medicine framework to fall back on if something goes wrong.